Periprosthetic Joint Infections
New Generation of Treatment Strategies, Antibiotics, and Outcomes
Part 1
Part 2
Part 3
Part 4
Periprosthetic joint infection (PJI) is associated with significant morbidity, mortality, and costs. Even with resolution, risk of recurrent infection is a significantly increased, however prevention strategies and treatments are evolving. Dr. William Jiranek and Dr. Jessica Seidelman will discuss PJI challenges and strategies for improving PJI outcomes.
This program is accredited for a total of 1 hour of credit for physicians, nurses, pharmacists, and laboratory professionals.
This program is accredited for a total of 1 hour of credit for physicians, nurses, pharmacists, and laboratory professionals.
William A. Jiranek, MD
Professor
Orthopaedic Surgery
Duke University
Dr. William Jiranek is a professor of orthopedic surgery at Duke University. He works in adult reconstructive orthopedics, predominantly with hip and knee replacement surgeries. He also manages revision surgeries and takes care of people with infections or fractures around their implants. Dr. Jiranek’s research focuses on tissue-guided restoration of the articular cartilage of the knee, joint infections, and the immune response to biomaterials.
Jessica L. Seidelman, MD, MPH
Associate Professor
Infectious Diseases
Duke University
Dr. Seidelman is an associate professor of medicine at Duke University specializing in infectious diseases with a clinical interest in musculoskeletal infections. She has a particular interest in surgical site infection prevention. Dr. Seidelman is co-director for the Duke University musculoskeletal infection program and the Duke Infection Control Outbreak Network, which serves many hospitals across the Southeast United States. She is also content creator and co-host of the podcast, Joint Approach, which is the official podcast of the Musculoskeletal Infection Society.